Research progress of ulinastatin in treatment of COVID-19
Drug Evaluation Research
; 45(1):186-192, 2022.
Article
in Chinese
| Scopus | ID: covidwho-1912086
ABSTRACT
Coronavirus disease 2019 (COVID-19) is still spreading worldwide. At present, no specific drug has been developed for the virus. Ulinastatin plays an important role in anti-inflammatory. Clinically, it is mainly used in acute pancreatitis, shock and disseminated intravascular coagulation. It also has the effects of antioxidant stress, anticoagulation and immune regulation, which may be of great significance to reduce the severity and mortality of COVID-19. Combined with the pharmacological effect of ulinastatin and its clinical application in the treatment of COVID-19 complications such as acute respiratory distress syndrome and sepsis lung injury, this paper discusses the feasibility of its application in COVID-19, so as to provide help for the clinical treatment and new drug research and development of this disease. © 2022 Tianjin Press of Chinese Herbal Medicines. All Rights Reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Language:
Chinese
Journal:
Drug Evaluation Research
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS